Christina Fotopoulou

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 279 publications

FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.

FIGO/IGCS Statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 01, 2026

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].

Corrigendum to "SUROVA Study: Global Real-World Treatment Strategies And Mortality Risk Prediction In Advanced Ovarian Cancer" [International Journal of Gynecological Cancer 36 (2026) 102688].

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: July 30, 2026

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Abstracts of the 36th World Congress on Ultrasound in Obstetrics and Gynecology, 4-7 September 2026, London, UK.

Journal: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Published: July 06, 2026

Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review.

Treatment strategies for oligometastatic and oligorecurrent epithelial ovarian cancer: a narrative review.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 22, 2026

FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.

FIGO/IGCS statement on the efficacy of topical treatments for high-risk human papillomavirus in preventing CIN 3+ lesions.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: June 20, 2026

Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".

Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 07, 2026

Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98].

Corrigendum to 'Endometriosis and ovarian cancer risk' [Gynecologic Oncology 209C (2026) 88-98].

Journal: Gynecologic oncology
Published: June 02, 2026

Now or Later? Defining the Ideal Time for Surgical Cytoreduction in Advanced Ovarian Cancer.

Now or Later? Defining the Ideal Time for Surgical Cytoreduction in Advanced Ovarian Cancer.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 22, 2026

Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort.

Early death and early relapse in advanced ovarian cancer: distinct clinical phenotypes in the International SUROVA cohort.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 19, 2026

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update.

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update.

Journal: Gynecologic oncology
Published: May 16, 2026

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Malignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyond.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 06, 2026

Primary ovarian malignant melanoma: A systematic review of cases and pooled analysis.

Primary ovarian malignant melanoma: A systematic review of cases and pooled analysis.

Journal: Gynecologic oncology
Published: April 20, 2026
Showing 1-12 of 279

Last Updated: 09/26/2026